POSA243 Approaches to Immune Checkpoint Inhibitor (ICI) First-Line Maintenance Therapy (1L-MT) in Unresectable Locally Advanced (LA) or Metastatic Urothelial Cancer (mUC) in France, Germany, Italy, Spain, and the UK (EU5)
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.758
https://www.valueinhealthjournal.com/article/S1098-3015(21)02553-5/fulltext
Title :
POSA243 Approaches to Immune Checkpoint Inhibitor (ICI) First-Line Maintenance Therapy (1L-MT) in Unresectable Locally Advanced (LA) or Metastatic Urothelial Cancer (mUC) in France, Germany, Italy, Spain, and the UK (EU5)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02553-5&doi=10.1016/j.jval.2021.11.758
First page :
Section Title :
Open access? :
No
Section Order :
10287